Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/28/2014 | US8637669 Production method for adefovir dipivoxil |
01/28/2014 | US8637664 Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
01/28/2014 | US8637662 Isoxazolidine derivatives |
01/28/2014 | US8637610 Crosslinked polymers containing biomass derived materials |
01/28/2014 | US8637578 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins |
01/28/2014 | US8637577 Desensitizing drug product |
01/28/2014 | US8637576 Benzamide derivatives and uses related thereto |
01/28/2014 | US8637575 Modulators of protein kinase signaling |
01/28/2014 | US8637574 Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof |
01/28/2014 | US8637573 N-acetyl-L-cysteine for the treatment of endometriosis |
01/28/2014 | US8637571 Compositions and methods for the intraocular transport of therapeutic agents |
01/28/2014 | US8637570 Pharmaceutical composition |
01/28/2014 | US8637569 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
01/28/2014 | US8637568 Serotonin reuptake inhibitors |
01/28/2014 | US8637567 Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid |
01/28/2014 | US8637566 Slow infusion of sulcardine and its salts |
01/28/2014 | US8637565 Salinosporamides and methods for use thereof |
01/28/2014 | US8637564 Methods and compositions for inducing apoptosis by stimulating ER stress |
01/28/2014 | US8637563 Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes |
01/28/2014 | US8637562 Methods for detecting sulfhydryl-containing compounds in a biological test sample |
01/28/2014 | US8637561 Linked diimidazole derivatives |
01/28/2014 | US8637560 Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment |
01/28/2014 | US8637559 Oxazole compound and pharmaceutical composition |
01/28/2014 | US8637558 Thiazolidinedione derivative and use thereof |
01/28/2014 | US8637557 Aminothiazole derivative |
01/28/2014 | US8637556 Linked Myc-max small molecule inhibitors |
01/28/2014 | US8637555 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
01/28/2014 | US8637554 Methods for treating thyroid cancer |
01/28/2014 | US8637553 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
01/28/2014 | US8637551 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives |
01/28/2014 | US8637550 Heteroaryl diamide compounds useful as MMP-13 inhibitors |
01/28/2014 | US8637549 Pyridons as PDK1 inhibitors |
01/28/2014 | US8637548 Therapeutic agents useful for treating pain |
01/28/2014 | US8637547 Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases |
01/28/2014 | US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
01/28/2014 | US8637545 Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors |
01/28/2014 | US8637544 Neurite formation promoter |
01/28/2014 | US8637543 Quinoline derivatives as kinase inhibitors |
01/28/2014 | US8637542 Kinase inhibitors and methods of use |
01/28/2014 | US8637541 Indole derivatives as CRTH2 receptor antagonists |
01/28/2014 | US8637540 Compositions for deterring abuse of opioid containing dosage forms |
01/28/2014 | US8637539 Remedies for neuropathic pain and model animals of neuropathic pain |
01/28/2014 | US8637537 Serine/threonine kinase inhibitors |
01/28/2014 | US8637536 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 |
01/28/2014 | US8637535 Polymorphic and other crystalline forms of cis-FTC |
01/28/2014 | US8637534 Fungicide active substance combinations |
01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
01/28/2014 | US8637532 Amino azaheterocyclic carboxamides |
01/28/2014 | US8637531 Pyrido(3,2-d)pyridmidines useful for treating viral infections |
01/28/2014 | US8637530 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
01/28/2014 | US8637529 Pyrazolo[3,4-d]pyrimidine compounds |
01/28/2014 | US8637528 Use of PDE7 inhibitors for the treatment of movement disorders |
01/28/2014 | US8637527 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
01/28/2014 | US8637526 Pyrazolopyrimidine JAK inhibitor compounds and methods |
01/28/2014 | US8637525 Compounds for the reduction of beta-amyloid production |
01/28/2014 | US8637524 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 |
01/28/2014 | US8637521 Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds |
01/28/2014 | US8637520 Substituted pyridyl amide compounds as modulators of the histamine H3 receptor |
01/28/2014 | US8637519 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
01/28/2014 | US8637518 Pyridazinone derivatives |
01/28/2014 | US8637517 Organic compounds |
01/28/2014 | US8637516 Compounds and compositions as TRK inhibitors |
01/28/2014 | US8637515 Polymorphs of brimonidine pamoate |
01/28/2014 | US8637514 Polymorphs of brimonidine pamoate |
01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
01/28/2014 | US8637512 Formulations and method of treatment |
01/28/2014 | US8637511 Aminopyrimidines useful as kinase inhibitors |
01/28/2014 | US8637510 Morpholinothiazoles as alpha 7 positive allosteric modulators |
01/28/2014 | US8637509 Azaindazoles |
01/28/2014 | US8637508 Heterocyclic derivatives and their use in the treatment of neurological disorders |
01/28/2014 | US8637507 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
01/28/2014 | US8637506 Compositions and methods for bone formation and remodeling |
01/28/2014 | US8637505 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
01/28/2014 | US8637504 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
01/28/2014 | US8637503 Phenothiazine enantiomers as agents for the prevention of bone loss |
01/28/2014 | US8637502 2,3,4,5-tetrahydro-benzo{B}{1,4}diazepine-comprising compounds of formula(III) for treating pain |
01/28/2014 | US8637501 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
01/28/2014 | US8637500 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
01/28/2014 | US8637499 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture |
01/28/2014 | US8637498 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
01/28/2014 | US8637497 AZA spiro alkane derivatives as inhibitors of metalloproteases |
01/28/2014 | US8637496 Compounds having a monogalactosyldiacylglycerol synthase inhibitory activity as herbicide or algaecide, herbicide and algaecide compositions |
01/28/2014 | US8637495 Osteoarthritis diet formulations |
01/28/2014 | US8637494 Method of achieving normoglycemia in diabetics by administration of Withaferin A |
01/28/2014 | US8637493 Methods for treating glioblastoma |
01/28/2014 | US8637492 Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitates delivery into cells in vivo |
01/28/2014 | US8637491 Thieno-pyridine derivatives as MEK inhibitors |
01/28/2014 | US8637490 Anti-cancer agents |
01/28/2014 | US8637489 Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions |
01/28/2014 | US8637488 Extract obtained from orchidaceae plants, method for producing the extract, and external agent for skin comprising the extract |
01/28/2014 | US8637487 Nutritional products comprising saccharide oligomers |
01/28/2014 | US8637486 Therapeutic substances that modulate genome methylation |
01/28/2014 | US8637485 5′,-substituted adenosynes preparation thereof and use as inhibitors of S-adenosylmethionine decarboxylase |
01/28/2014 | US8637484 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
01/28/2014 | US8637475 Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections |
01/28/2014 | US8637474 Receptor modulators exhibiting neuroprotective and memory enhancing activities |
01/28/2014 | US8637473 Synthetic membrane anchors |
01/28/2014 | US8637453 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
01/28/2014 | US8637452 Water soluble membrane proteins and methods for the preparation and use thereof |
01/28/2014 | US8637087 Treatment of interstitial cystitis using (6aR, 10aR)-Δ8-tetrahydrocannabinol-11-OIC acids |